These stocks have an unusual volume in today's session

SPERO THERAPEUTICS INC (SPRO)       1.86   -0.03 (-1.59%)

After market: 1.88 +0.02 (+1.08%)


News Image
These stocks have an unusual volume in today's session4 months ago - Chartmill

Let's have a look at what is happening on the US markets on Monday. Below you can find the stocks with an unusual volume in today's session.

Top unusual volume stocks

TickerChangeComment
LITM-33.18%SNOW LAKE RESOURCES LTD (NASDAQ:LITM) has an unusual volume of 4.21M shares. NASDAQ:LITM is declining 33.18% today. The average daily volume over 50 days is 1.76M, so this is 139.0% above the average volume.
NAOV-19.39%NANOVIBRONIX INC (NASDAQ:NAOV) has an unusual volume of 627.94K shares today. The share price decreased by 19.39%. The average volume measured over 50 days is 443.8K, so this is 41.49% above the average volume.
SONX-6.69%SONENDO INC (NYSE:SONX) has an unusual volume of 745.29K shares. Shares are falling by 6.69%. This is 62.7% above the average daily volume of the last 50 days.
ISPC13.6%13.41M shares of ISPECIMEN INC (NASDAQ:ISPC) exchanged hands today. Leading to a price increase of 13.6%. This is 12.0K% above the average daily volume of the last 50 days.
MDGS-5.89%So far 379.32K shares of MEDIGUS LTD - SPON ADR (NASDAQ:MDGS) have traded in today's session. The share price decreased by 5.89%. This volume is 183.0% above the average 50 day volume.
FENC-11.24%FENNEC PHARMACEUTICALS INC (NASDAQ:FENC) has an unusual volume of 264.72K shares today. Shares are falling by 11.24%. This is 101.0% above the average daily volume of the last 50 days.
SPRO2.28%SPERO THERAPEUTICS INC (NASDAQ:SPRO) has an unusual volume of 10.64M shares. The share price increased by 2.28%. The average volume measured over 50 days is 8.53M, so this is 24.79% above the average volume.
TPGY-0.1%911.0K shares of TPG PACE BENEFICIAL FIN-CL A (NYSE:TPGY) have been traded so far today. NYSE:TPGY is declining 0.1% today. The average volume measured over 50 days is 145.45K, so this is 526.0% above the average volume.
CCVI0.02%564.65K shares of CHURCHILL CAPITAL CORP VI-A (NYSE:CCVI) have been traded so far today. Shares are rising by 0.02%. This is 313.0% above the average daily volume of the last 50 days.
SAI-9.09%SAITECH GLOBAL CORP's (NASDAQ:SAI) traded a high volume of 225.08K shares. Shares are falling by 9.09%. The average daily volume over 50 days is 181.02K, so this is 24.34% above the average volume.

For the full unusual volume stocks list go to our unusual volume stocks screener.

Back

SPRO Links

SPRO News

News Image7 days ago - Spero Therapeutics, Inc.Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...

News Image2 months ago - Spero Therapeutics, Inc.Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...

News Image3 months ago - Spero Therapeutics, Inc.Spero Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference

CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical...

News Image3 months ago - Spero Therapeutics, Inc.Spero Therapeutics Announces Third Quarter 2022 Operating Results and Provides Business Update

Entered into and closed exclusive license agreement with GSK for tebipenem HBr, pursuant to which Spero receives $66 million upfront, and a $9 million...

News Image3 months ago - Spero Therapeutics, Inc.Spero Therapeutics Announces Closing of Exclusive License Agreement with GSK for Tebipenem HBr

Pursuant to the agreement, Spero will be receiving a $66 million upfront payment, received a $9 million direct equity investment in shares of Spero common...

News Image3 months ago - Spero Therapeutics, Inc.Spero Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

CAMBRIDGE, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...

News Image4 months ago - Spero Therapeutics, Inc.Spero Therapeutics to Present Data at IDWeek 2022

CAMBRIDGE, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...

News Image4 months ago - Spero Therapeutics, Inc.Spero Therapeutics to Host Virtual R&D Event on Non-Tuberculous Mycobacterial Pulmonary Disease and the SPR720 Program

Event is taking place on Thursday, October 6th at 11:30 a.m. ET Event will feature a presentation by key opinion leader, Kevin L. Winthrop, MD, MPH...

Follow us for more